Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer

Journal:

Nature Communications

Published:

2025-11-23

DOI:

10.1038/s41467-025-66485-2

Affiliations:

9

Authors:

38

Go to article

Institutions	Authors	Share
Kyoto University, Japan	29.500000 29.500000 29.500000	0.78
Osaka Metropolitan University (OMU), Japan	5.000000	0.13
Weill Cornell Medicine, United States of America (USA)	2.000000	0.05
Kyoto University Hospital, Japan	1.000000	0.03
WPI Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Japan	0.500000	0.01

Interested in Oncology and Carcinogenesis?